PRO 140

leronlimab · CytoDyn, Inc.

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for PRO 140, covering 2013-05-31 to 2025-09-16. Get the full timeline:

Most recent: Clinical Trial Update: PRO 140 in Treatment-Experienced HIV-1 Subjects [Phase 2, Phase 3]